Clinical Trials · NCT00488722
A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast Cancer
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- Tianjin Medical University
- Enrollment
- 0
- Start date
- Apr 2007
- Locations
- 1 site, China
- Primary endpoint
- To evaluate the efficacy of concurrent Zoladex and CEF as neoadjuvant regimen in terms of: ORR(CR+PR) and PCR